Santen Pharmaceutical

(OTC) SNPHF

Current Price$13.05

Market Cap$4.20B

Since IPO (2004)-17%

5 Year+6%

1 Year+17%

1 Month+20%

Santen Pharmaceutical Financials at a Glance

Market Cap

$4.20B

Revenue (TTM)

¥293.18B

Net Income (TTM)

¥37.58B

EPS (TTM)

$0.75

P/E Ratio

17.35

Dividend

$0.25

Beta (Volatility)

0.06 (Low)

Dividend

$0.25

Beta (Volatility)

0.06 (Low)

Price

$13.05

Volume

Open

$13.06

Price

$13.05

Volume

Open

$13.06

Previous Close

$13.05

Daily Range

$13.05 - $13.06

52-Week Range

$8.88 - $13.06

Estimated Earnings Date

Aug 6, 2026

Dividend

$0.25

Beta (Volatility)

0.06 (Low)

Price

$13.05

Volume

Open

$13.06

Previous Close

$13.05

Daily Range

$13.05 - $13.06

52-Week Range

$8.88 - $13.06

Estimated Earnings Date

Aug 6, 2026

SNPHF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Santen Pharmaceutical

Industry

Pharmaceuticals

Sector

Health Care

Employees

3,968

CEO

Takeshi Ito

Website

www.santen.co.jp

Headquarters

Osaka, 530-8552, JP

SNPHF Financials

Key Financial Metrics (TTM)

Gross Margin

55.20%

Operating Margin

15.50%

Net Income Margin

12.81%

Return on Equity

13.15%

Return on Capital

13.63%

Return on Assets

8.83%

Earnings Yield

5.76%

Dividend Yield

1.90%

Payout Ratio

33.84%

Stock Overview

Market Cap

$4.20B

Shares Outstanding

321.69M

Volume

Avg. Volume

16.258

Financials (TTM)

Gross Profit

¥164.03B

Operating Income

¥45.52B

EBITDA

¥64.73B

Operating Cash Flow

¥36.06B

Capital Expenditure

-¥5.04B

Free Cash Flow

¥31.02B

Cash & ST Invst.

¥83.35B

Total Debt

¥34.97B

Santen Pharmaceutical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2026YOY CHG

Revenue

¥81.37B

+5.4%

Gross Profit

¥49.98B

+8.4%

Gross Margin

61.43%

N/A

Market Cap

$4.20B

N/A

Market Cap/Employee

$1.12M

N/A

Employees

3,744

N/A

Net Income

¥15.64B

+77.9%

EBITDA

¥21.76B

+17.7%

Quarterly Fundamentals

Name

Q4 2026YOY CHG

Total Cash

¥83.35B

-11.3%

Total Debt

¥34.97B

+2.2%

Accounts Receivable

¥72.28B

+0.7%

Inventory

¥64.99B

+26.0%

Long Term Debt

¥0.00

N/A

Short Term Debt

¥3.56B

+8.1%

Return on Assets

8.83%

N/A

Return on Invested Capital

13.49%

N/A

Free Cash Flow

¥19.21B

+6.9%

Operating Cash Flow

¥21.11B

+11.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

DNPUFSumitomo Pharma Co., Ltd.

DNPUFSumitomo Pharma Co., Ltd.$9.41+0.00%

BUHPFBumrungrad Hospital Public Company Limited

BUHPFBumrungrad Hospital Public Company Limited$5.45+0.00%

CAMRFCamurus AB

CAMRFCamurus AB$61.01+0.00%

CZMWYCarl Zeiss Meditec AG

CZMWYCarl Zeiss Meditec AG$31.65+4.35%

CZMWFCarl Zeiss Meditec AG

CZMWFCarl Zeiss Meditec AG$30.00+0.00%

OPHLYOno Pharmaceutical Co., Ltd.

OPHLYOno Pharmaceutical Co., Ltd.$4.83-0.41%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$37.88+0.04%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.50+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.46-0.04%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$157.54-0.08%

SOFISoFi Technologies

SOFISoFi Technologies$18.44+0.03%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$33.96+0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.34+0.02%

Questions About SNPHF

What is the current price of Santen Pharmaceutical?

Santen Pharmaceutical is trading at $13.05 per share.

What is the 52-week range for Santen Pharmaceutical?

Over the past 52 weeks, Santen Pharmaceutical has traded between $8.88 and $13.06.

How much debt does Santen Pharmaceutical have?

As of the most recent reporting period, Santen Pharmaceutical reported total debt of ¥218.44M.

How much cash does Santen Pharmaceutical have on hand?

Santen Pharmaceutical reported ¥508.36M in cash and cash equivalents in its most recent financial results.

What is Santen Pharmaceutical’s dividend yield?

Santen Pharmaceutical currently has a dividend yield of 1.90%.

Santen Pharmaceutical

Santen Pharmaceutical Financials at a Glance

SNPHF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Santen Pharmaceutical

SNPHF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Santen Pharmaceutical Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SNPHF

What is the current price of Santen Pharmaceutical?

What is the 52-week range for Santen Pharmaceutical?

How much debt does Santen Pharmaceutical have?

How much cash does Santen Pharmaceutical have on hand?

What is Santen Pharmaceutical’s dividend yield?

Premium Investing Services